Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

30.66
+0.15000.49%
Volume:1.88M
Turnover:57.45M
Market Cap:3.58B
PE:-6.57
High:31.09
Open:30.85
Low:30.15
Close:30.51
52wk High:43.15
52wk Low:25.77
Shares:116.65M
Float Shares:110.00M
Volume Ratio:1.08
T/O Rate:1.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:8.76
PE(LYR):-9.61

Loading ...

OverviewCompanyNewsFilings

Movement Alert｜Viking Therapeutics Rises 5.31% in Regular Trading, Obesity Drug VK2735 Maintenance Data Continues to Fuel Rally

Market Focus
·
Sep 24

Viking Therapeutics Price Target Raised to $87.00/Share from $83.00 by Truist Securities

Dow Jones
·
Sep 24

Leerink Partners Sticks to Their Buy Rating for Viking Therapeutics (VKTX)

TIPRANKS
·
Sep 23

The Stock Market is Sleeping on the Next Big AI Catalyst

Dow Jones
·
Sep 23

Canaccord Genuity Remains a Buy on Viking Therapeutics (VKTX)

TIPRANKS
·
Sep 23

These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.

Dow Jones
·
Sep 23

Viking Therapeutics, Inc. : Truist Securities Raises Target Price to $87 from $83

THOMSON REUTERS
·
Sep 23

Small U.S. Stocks Close Up; Viking Therapeutics Leads Increases

Dow Jones
·
Sep 23

Viking Therapeutics price target raised to $120 from $100 at Oppenheimer

TIPRANKS
·
Sep 23

Top Midday Stories: Goldman Reportedly in Talks to Acquire $37 Billion Credit Firm Palmer Square; Viking Obesity Drug Candidate Showed 'Superior' Results in Study

MT Newswires Live
·
Sep 22

This GLP-1 Drug Helped People Maintain Their Weight Loss in a Clinical Trial - Even for Those Taking it Once a Month

Dow Jones
·
Sep 22

U.S. Stocks on the MOVE-Greenland Mines, GameStop, Shopify

Reuters
·
Sep 22

Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial

Dow Jones
·
Sep 22

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)

TIPRANKS
·
Sep 22

Viking Therapeutics Phase 1 data ‘highly encouraging,’ says H.C. Wainwright

TIPRANKS
·
Sep 22

Viking Therapeutics obesity data ‘very positive,’ says Morgan Stanley

TIPRANKS
·
Sep 22

Viking Therapeutics Maintains Buy Rating as VK2735 Data De-Risk Obesity Strategy; $83 Price Target Reaffirmed

TIPRANKS
·
Sep 22

Sandisk, GameStop, Viking Therapeutics, Vicor, on Holding, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 22

Viking Therapeutics obesity data ‘best-case scenario,’ says Truist

TIPRANKS
·
Sep 22

Under the Rader: Viking Stock Gains on Weight-Loss Study

Dow Jones
·
Sep 22
More